Burkitt Lymphoma (Disease Or Phenotype)

Omim:MTHU070634

Nci:C2912

Msh:D002051

Mondo:MONDO:7243

Medcin:MEDCIN:31690

Mdr:MDR:10006596

Id:d907a6a8-a016-5b43-94df-d8aa4d91c488

Icpc2icd10eng:MTHU046845

Icd10cm:C83.7

Efo:EFO:309

Doid:DOID:8584

Chv:CHV:2229

Linked to

	Label	Description
	doxorubicin indication Burkitt Lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Methotrexate indication Burkitt Lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Vincristine indication Burkitt Lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Dexamethasone indication Burkitt Lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

doxorubicin indication Burkitt Lymphoma

A Knowledge Graph Assertion from IDG

Methotrexate indication Burkitt Lymphoma

A Knowledge Graph Assertion from IDG

Vincristine indication Burkitt Lymphoma

A Knowledge Graph Assertion from IDG

Dexamethasone indication Burkitt Lymphoma

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.